The aim of this work was to determine the levels of urinary human tissue non-specific alkaline phosphatase (hTNAP) in pre-eclampsia and eclampsia in order to assess renal tubular damage. Urine samples were collected from 26 mild pre-eclamptic, 26 severe pre-eclamptic, 20 eclamptic patients and 20 healthy pregnant women (controls) in their late third trimester. Urinary hTNAPfcreatinine (hTNAPfcr) in severe pre-eclampsia and eclampsia were significantly higher than in controls. Urinary hTNAPfcr was increased in 23%, 77% and 90% of cases of mild pre-eclampsia, severe pre-eclampsia and eclampsia, respectively, indicating that the increase correlates with the severity of the disease. Marked elevation or urinary hTNAPfcr was also associated with bad fetal outcome. These results provide additional evidence for renal tubular damage in pre-eclampsia and eclampsia.
SUMMARY. The aim of this work was to determine the levels of urinary human tissue non-specific alkaline phosphatase (hTNAP) in pre-eclampsia and eclampsia in order to assess renal tubular damage. Urine samples were collected from 26 mild pre-eclamptic, 26 severe pre-eclamptic, 20 eclamptic patients and 20 healthy pregnant women (controls) in their late third trimester. Urinary hTNAPfcreatinine (hTNAPfcr) in severe pre-eclampsia and eclampsia were significantly higher than in controls. Urinary hTNAPfcr was increased in 23%, 77% and 90% of cases of mild pre-eclampsia, severe pre-eclampsia and eclampsia, respectively, indicating that the increase correlates with the severity of the disease. Marked elevation or urinary hTNAPfcr was also associated with bad fetal outcome. These results provide additional evidence for renal tubular damage in pre-eclampsia and eclampsia.
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Although glomerular dysfunction associated with pre-eclampsia has been investigated, few studies of tubular dysfunction during normal pregnancy and pre-eclampsia have been reported.' The characteristic lesion in pre-eclampsia and eclampsia is a renal glomerular endotheliosis which leads to reduced glomerular blood flow and glomerular filtration rate.? Immunofluorescent techniques have been used to demonstrate the presence of fibrin-fibrinogen, immunoglobulins and complement in the glomerular mesangium of the capillary vessel walls. Renal tubules usually show abnormalities consistent with ischaemia and proteinaceous material is often found within the tubular lumen. Ischaemia and microinfarcts of the kidney which occur in pre-eclampsia could induce renal tubular cells to release enzymes into the urine. Elevation of urinary N-acetyl fJ-Dglucosaminidase and alanine aminopeptidase activities were found to indicate subclinical preeclamptic renal tubular damage.'
In the last two decades, attempts have been made to develop non-invasive markers of the anatomical site, severity, and nature of acute Correspondence: Professor Mohamed Shaarawy, 21 E1-Khalifa EI-Maamoun Street, Apartment 701, Roxy Building, Heliopolis, Cairo, Egypt. renal injury, by measuring urinary enzymes.v" However, enzyme activity methods have low specificity for the site and pathology of injury, and the enzymes are often unstable in urine, which led to the search for monoclonal antibodies to tubular antigens as more specific markers." Several monoclonal antibodies have been characterized which detect antigens specific to certain segments of the nephron." Further, immunoassays using these monoclonal antibodies have detected urinary enzymes, allowing their evaluation as markers of renal injury.7-9 One enzyme examined in the human kidney has been alkaline phosphatase, with its several isoenzymes. The human kidney contains two antigenically distinct alkaline phosphatase isoenzymes, tissue non-specific alkaline phosphatase (hTNAP) and intestinal alkaline phosphatase (IAP), both contributing to alkaline phosphatase activity in urine. 4 , IO, 1l lAP is exclusively in the brush border of the S3 cells of the proximal tubule, whereas hTNAP is located throughout the entire proximal tubule.'! This contrasts with many other urinary markers, e.g. N-acetylglucosaminidase, which is found throughout the proximal tubal as well as in renal papillae and glomeruli.P Verpouten et af.l2 using monoclonal based enzyme immunoassays
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found that approximately 25% of the total alkaline phosphatase content of renal tissue at the transition between cortex and medulla was of the intestinal type, the remainder was of the tissue non-specific type. Mapping antigens to specific parts of the tubule using monoclonal antibody based techniques offers the possibility of sensitive and specific indirect test of the site, pathology and severity of renal injury. Urinary enzyme measurement reflecting tubular damage may become abnormal before more conventional markers of renal function." A prospective study of urinary lAP and hTNAP in acute renal failure using monoclonal antibody-based immunoassays showed the median hTNAP concentrations were higher in patients with a poor prognosis."
This study was undertaken to determine the activities of urinary hTNAP in pre-eclampsia and eclampsia in order to assess proximal renal tubular damage.
PATIENTS AND METHODS
Ninety-two nulliparous pregnant women in their late third trimester attending the antenatal clinic of AI-Zahraa University Hospital, AI-Azhar University, Cairo were studied over a period of 1 year from September 1994 to August 1995. They were divided into four groups. The first comprised 20 normotensive healthy pregnant women who served as controls; the second 26 cases of mild pre-eclampsia; the third 26 cases of severe pre-eclampsia; and the fourth 20 cases of eclampsia. Pre-eclampsia was defined as a blood pressure of~140mmHg systolic or 90mmHg diastolic, plus proteinuria,~300 mg per 24 h or 2 + by dipstick, both occurring on two occasions at least 4 h apart. Mild and severe pre-eclampsia were subgrouped according to the criteria of Cunningham et al. l s Mild preeclampsia was defined as: (I) an absolute blood pressure~140mmHg or an increase of at least 30 mmHg systolic or 15mm diastolic over baseline in the first 20 weeks of pregnancy; and (2) proteinuria (:0::;; 300 mg per 24 h). The criteria for severe pre-eclampsia were: (I) blood pressurẽ 160mmHg or~100mmHg diastolic; and (2) proteinuria > 5 g per 24 h, in addition to oliguria (~4oomL in 24 h), cerebral or visual disturbances, epigastric pain or pulmonary oedema. Urinary total protein was measured by precipitation of proteins in urine by trichloroacetic acid and quantitation by turbidimetry at 620nm where standardization was made against appropriately diluted quality control serum." Pre-eclamptic patients who developed convulsions were considered to be suffering from eclampsia. Control women were matched with those with pre-eclampsia for race, maternal age and gestational age at delivery and urine sampling.
Patients with a prior history of chronic hypertension, diabetes, renal or cardiovascular disease were excluded. All controls delivered vaginally. Two of 26 mild pre-eclamptic cases underwent elective Caesarean section, one because of developing signs of fetal distress as shown by electrocardiography and the other because of cephalopelvic disproportion. Five cases of severe pre-eclampsia underwent elective Caesarean section because of failure to control the rise of blood pressure and developing signs of impending eclampsia. All eclamptic patients underwent elective Caesarean section because they were not in labour. Birth weight and Apgar score (AS) were assessed immediately after delivery. This scoring system is a quick method of assessing the state of newborn, applied at I min and again at 5 min after birth. It evaluates heart beat, respiratory effort, muscle tone, reflex irritability and skin colour. Abnormal AS (below 6) indicates depressed respiration, slow heart rate, flaccidity, depressed reflex response and pale to blue skin colour. In the pre-eclamptic and eclamptic cases, there were 10 still births (SB). Low AS babies (below 6) were encountered in 30 of 72 pre-eclamptic and eclamptic cases. From each case that participated in this study a morning urine sample was taken before the administration of any drug known to affect blood pressure and before any medical intervention, i.e. before intravenous administration of hydralazine for acute control of severe hypertension in severe pre-eclampsia or before parenteral magnesium sulphate therapy for eclampsia. Freshly voided urine samples were added to a stabilizing buffer in a proportion of I mL urine sample to 50 J-lL of stabilizing buffer which contained imidazole with benzamidine, aprotinin, triton X-IOO and sodium azide. Insoluble material was removed from all samples by centrifugation before testing. Urine samples were stored at -80 DC until assay. Urinary hTNAP was determined by an enzyme antigen immunoassay (EAIA) using a high-affinity monoclonal antibody to capture the hTNAP present in urine. The assay is specific for hTNAP and shows less than 0·1% cross-reactivity with placental or intestinal alkaline phosphatase isoenzymes. The polystyrene wells were coated with monoclonal anti-hTNAP (antibody to hTNAP). Sample diluent (100 ilL) was added to each well reserved for specimen or standards followed by 100ilL of standard or stabilized urine in duplicate and incubated overnight (16 h) at room temperature (l5°-30°C). Each well was washed three times with 0·3 mL wash solution (phosphate buffer) and after the last wash, blotted dry to remove residual wash solution. Two hundred microlitres of substrate solution (prepared by dissolving one tablet of p-nitrophenyl phosphate in 30 mL Nethyl-aminoethanol) was added to each well and incubated at room temperature. The absorbance of the solution in the wells was read at 405 nm blanked against zero standard or air after incubation for 15,30,60 and 120min (according to the concentration of hTNAP). For specimens containing hTNAP concentrations above 10IU /L, the sample was further diluted with sample diluent. Urinary hTNAP results were expressed as the urinary hTNAP creatinine ratio (lU/g creatinine). The intra-assay coefficient of variation [(CV) (10 parallel measurements of four urine samples with different hTNAP activities)] was 3·8%. The inter-assay VC (a urine sample stored at 4°C assayed on 10 consecutive days) was 4·2%. The detection limit of 0'02IU, calculated as the man (+ 3 SD) for 12 replicates of the zero standard, was well below the lowest urine hTNAP activities encountered in normal controls. Conventional laboratory methods were used for serum urea, serum creatinine and creatinine clearance. Urinary hTNAP activities in pathological and control groups were compared by Student's t test of significance and by analysis variance with appropriate post hoc testing using Tuken's honestly significant difference (HSD) procedure.!?
RESULTS
Clinical and demographic data from pre-eclamptic and control groups are summarized in Table  I . As anticipated from definition criteria, systolic and diastolic pressures at term were significantly higher in the pre-eclamptic group than in the normotensive pregnant group. Gestational ages at delivery and infant birth weights were significantly lower in the pre-eclamptic group compared to the normotensive pregnant women. None of the infant birth weights in the normotensive pregnant group were below the tenth percentile for gestational age (small for gestational age), in contrast to 30 of the infants in the pre-eclamptic and eclamptic groups were small for gestational age.
Biochemical renal profile showed that serum creatinine, blood urea nitrogen (BUN) and uric acid concentrations were significantly increased in severe pre-eclamptic and eclamptic women when compared to those of healthy normotensive pregnant women and creatinine clearance was significantly decreased in severe and eclamptic women. Serum creatinine, BUN, uric acid and creatinine clearance did not change significantly in mild pre-eclamptic women ( Table  2) . Proteinuria in mild pre-eclampsia varied between 0·3 to I g/24h urine whereas in severe cases it varied between O' 5 to 5 g/24 h. Proteinuria of more than 5 to 10 g/24 h were encountered in patients with eclampsia.
Urinary hTNAP/cr ratio, in mild pre-eclamptic, severe pre-eclamptic and eclamptic women were significantly higher than in controls (Table  3 ). Using Tuken's HSD procedure,'? eclamptic patients showed a significantly higher mean hTNAP/cr than for controls, mild or severe pre-eclamptic patients. However, there were no significant differences in mean hTNAP/cr between mild and severe pre-eclamptic patients.
Individual hTNAP/cr are illustrated in Fig. 1 . All women (100%) who delivered still births revealed values for hTNAP/cr of > 3·0. There were no significant differences in urinary hTNAP/cr in pre-eclamptic and eclamptic women who delivered low Apgar score babies compared with those with normal Apgar score babies. However, the mean value of urinary hTNAP/cr in those who delivered still births and low birth weight babies were significantly higher than the corresponding values for those who delivered normal Apgar score or normal birth weight babies (Tables 4, 5) .
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DISCUSSION
Urinary enzymes, lAP and hTNAP appear to be useful in determining the site of renal injury.P lAP is exclusively present in the brush border of 83 cells of the proximal tubule whereas hTNAP is located throughout the entire proximal tubule.P The contribution of placental alkaline phosphatase to the increased activities of urinary hTNAP is questionable since the synthesis of alkaline phosphatase by the placental syncitiotrophoblast is known to be impaired in pre-eclampsia and eclampsia. However, if placental alkaline phosphatase was filtered at the glomerulus because of the Ann cu« Biochem 1997: 34 associated proteinuria, the specificity of the assay used for determination of hTNAP would severely limit this interference. In the present work, urinary hTNAP was assayed to evaluate tubular damage in pre-eclamptic toxaemia. There were significant elevations of urinary hTNAP/cr in mild and severe pre-eclampsia as well as in eclampsia when compared to the corresponding level of controls. All healthy pregnant women (controls) showed urinary hTNAP/cr values below 3IU/g. The increase of urinary hTNAP activity in eclampsia was more pronounced than that encountered in both mild and severe pre-eclampsia. This may be attributed to necrosis of the proximal tubular cells in eclampsia. The pathophysiology of pre-eclampsia includes ischaemia and microinfarctions of the kidney which could induce renal tubular cells to release enzymes into urine. Goren et al. 3 measured the concentrations of two markers of renal tubular damage. N-acetyl-p-D-glycosaminidase (NAG) and alanine aminopeptidase, in .
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urine specimens from women with mild or severe pre-eclampsia and compared the results with those from healthy pregnant women. They found that the median concentrations of the two enzymes were significantly higher in women with mild or severe pre-eclampsia and this increased enzyme secretion indicates subclinical preeclamptic renal tubular damage. In the present study the increased hTNAP excretion in women with pre-eclampsia and eclampsia may reflect renal ischaemia and relative hypertension of pregnancy. The striking increase in enzyme excretion in women with eclampsia suggests a tubular lesion consonant with arteriolar constriction and microinfarction. Renal tubular lesions are common in women with eclampsia, but have been interpreted as degenerative changes due to the accumulation within cells of proteins reabsorbed from the glomerular filtrate. The collecting tubules may appear obstructed by casts from derivatives of protein, including haemoglobin. Acute renal failure from tubular necrosis may develop. Although this is more common in neglected cases, it is invariably induced by haemorrhage, usually associated with delivery, for which adequate blood replacement is not given. Many of the low values for hTNAP in women with pre-eclampsia in this study might be ascribed to fluctuations (intermittent vasospasm) in the intensity of the disease. Nuyts et a/. 18 reported that urinary lAP, hTNAP and NAG were increased in workers exposed to mercury without apparent renal dysfunction. Similar observations have been made for NAG and other tubular proteins in various clinical contexts (e.g. infections or gentamicin treatment), when renal function was normal.l-'? In the present study most of mild pre-eclamptic cases having increased urinary hTNAP revealed normal serum creatinine and BUN levels. It seems that the raised enzyme values may reflect the sensitivity of the tubular enzymes to insult so that enzymuria begins before increases in serum creatinine or urea. Chew et al. 14 studied lAP and hTNAP in 50 cases of acute renal failure, urinary enzymes being measured at initial evaluation (start), and then each day for 14 days. They found that median enzymes concentrations were increased in poor compared to good prognosis patients. For lAP it was 3·2 versus 2'2IU/g creatinine (non-significant) and for hTNAP, it was 3·3 versus 0·9IU/g creatinine (significant at P<0·02). In the present study conventional laboratory tests of renal function (e.g. serum creatinine and creatinine clearance) were often within normal limits whereas urinary hTNAP was increased in patients with pre-eclamptic toxaemia. In 23% of cases of mild pre-eclampsia serum creatinine and creatinine clearance were normal but urinary hTNAP was increased. However, the overlap of values for hTNAP in women with pre-eclampsia with those for healthy women in the third trimester precludes any diagnostic use for individual patients. The clinical value of monitoring enzyme concentrations is limited to the detection of non-specific tubular damage because excretion is increased in patients with other renal diseases and by administration of many drugs. Nevertheless, longitudinal monitoring of selected patients at risk of developing the disease may be of value for investigation of subclinical renal tubular ischaemia. Ischaemic tubular damage may precede the development of glomerular endotheliosis and clinical overt pre-eclampsia.
Abnormal high values of urinary hTNAP were encountered in 77% of patients who delivered low Apgar score babies and in 100% of patients who delivered still births. The mean value of urinary hTNAP was also significantly elevated in patients who delivered low birth weight babies Ann cu« Biochem 1997: 34 when compared with those who delivered normal weight babies. On the other hand, high values of urinary hTNAP were also found in patients who delivered babies with normal Apgar score or normal birth weight (34% and 50%, respectively). These results severely limit the specificity of urinary hTNAP as a biochemical marker for the prediction of fetal outcome. However, markedly elevated values of urinary hTNAP/cr (40,52'8,56, 62IU/g) were detected in eclamptic women who delivered either low Apgar score babies, still birth of low birth weight babies. These results demonstrate that marked rise of urinary hTNAP/creatinine (more than l3-fold rise) may be associated with bad fetal outcome in pre-eclampsia and eclampsia.
